[go: up one dir, main page]

FI119913B - Kaikukontrastiaine - Google Patents

Kaikukontrastiaine Download PDF

Info

Publication number
FI119913B
FI119913B FI933137A FI933137A FI119913B FI 119913 B FI119913 B FI 119913B FI 933137 A FI933137 A FI 933137A FI 933137 A FI933137 A FI 933137A FI 119913 B FI119913 B FI 119913B
Authority
FI
Finland
Prior art keywords
negatively charged
composition according
polyoxyethylene polyoxypropylene
polyoxypropylene polymers
polyoxyethylene
Prior art date
Application number
FI933137A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI933137L (fi
FI933137A0 (fi
Inventor
Rudolf Linder
Klaus-Dieter Beller
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6422745&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI119913(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of FI933137L publication Critical patent/FI933137L/fi
Publication of FI933137A0 publication Critical patent/FI933137A0/fi
Application granted granted Critical
Publication of FI119913B publication Critical patent/FI119913B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Graft Or Block Polymers (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fish Paste Products (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Radiation-Therapy Devices (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
FI933137A 1991-01-09 1993-07-08 Kaikukontrastiaine FI119913B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4100470A DE4100470A1 (de) 1991-01-09 1991-01-09 Echokontrastmittel
DE4100470 1991-01-09
EP9200012 1992-01-04
PCT/EP1992/000012 WO1992011873A1 (fr) 1991-01-09 1992-01-04 Substance de contraste d'echo

Publications (3)

Publication Number Publication Date
FI933137L FI933137L (fi) 1993-07-08
FI933137A0 FI933137A0 (fi) 1993-07-08
FI119913B true FI119913B (fi) 2009-05-15

Family

ID=6422745

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933137A FI119913B (fi) 1991-01-09 1993-07-08 Kaikukontrastiaine

Country Status (25)

Country Link
US (1) US5599523A (fr)
EP (2) EP0494615A1 (fr)
JP (1) JP3290655B2 (fr)
KR (1) KR100203221B1 (fr)
AT (1) ATE126708T1 (fr)
AU (1) AU652803B2 (fr)
BG (1) BG61667B2 (fr)
CA (1) CA2098915C (fr)
CZ (1) CZ280939B6 (fr)
DE (3) DE4100470A1 (fr)
DK (1) DK0566601T4 (fr)
ES (1) ES2079176T5 (fr)
FI (1) FI119913B (fr)
GR (1) GR3017925T3 (fr)
HK (1) HK1006147A1 (fr)
HU (1) HU220763B1 (fr)
IE (1) IE70131B1 (fr)
IL (1) IL100607A (fr)
NZ (1) NZ241246A (fr)
PL (1) PL167253B1 (fr)
RU (1) RU2091079C1 (fr)
SK (1) SK278776B6 (fr)
UA (1) UA27121C2 (fr)
WO (1) WO1992011873A1 (fr)
ZA (1) ZA92118B (fr)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5922304A (en) * 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
US20040208826A1 (en) * 1990-04-02 2004-10-21 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US6989141B2 (en) * 1990-05-18 2006-01-24 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US6613306B1 (en) 1990-04-02 2003-09-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5578292A (en) 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
IN172208B (fr) * 1990-04-02 1993-05-01 Sint Sa
USRE39146E1 (en) 1990-04-02 2006-06-27 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US20010024638A1 (en) * 1992-11-02 2001-09-27 Michel Schneider Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
US7083778B2 (en) * 1991-05-03 2006-08-01 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US20030194376A1 (en) * 1990-05-18 2003-10-16 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5993805A (en) * 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
JP3231768B2 (ja) * 1991-09-17 2001-11-26 ソーナス ファーマシューティカルス，インコーポレイテッド 気体状超音波造影剤及び超音波造影剤として使用する気体の選定方法
US6875420B1 (en) 1991-09-17 2005-04-05 Amersham Health As Method of ultrasound imaging
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
IL104084A (en) 1992-01-24 1996-09-12 Bracco Int Bv Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
US5464696A (en) * 1992-08-13 1995-11-07 Bracco International B.V. Particles for NMR imaging
GB9221329D0 (en) 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
CZ191695A3 (en) 1993-01-25 1996-05-15 Sonus Pharma Inc Biologically compatible contrast agent, process of its preparation and representation method by ultrasound
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
CA2164813C (fr) 1993-07-30 2009-11-24 Ernest G. Schutt Composes de micro-bulles stabilisees servant d'agents contrastants
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
DE4328642A1 (de) * 1993-08-26 1995-03-02 Byk Gulden Lomberg Chem Fab Ultraschallkontrastmittel
GB9318288D0 (en) * 1993-09-03 1993-10-20 Nycomed Imaging As Improvements in or relating to contrast agents
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
HU225495B1 (en) * 1993-12-15 2007-01-29 Bracco Research Sa Gas mixtures useful as ultrasound contrast media
GB9417941D0 (en) * 1994-09-06 1994-10-26 Nycomed Imaging As Improvements in or relating to contrast agents
US5540909A (en) * 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
GB9423419D0 (en) 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
WO2004073750A1 (fr) 1995-06-07 2004-09-02 Harald Dugstad Ameliorations relatives a des agents de contraste
CA2246779C (fr) 1996-02-19 2008-04-29 Nycomed Imaging A/S Perfectionnements relatifs aux milieux de contraste
EP0904113B1 (fr) * 1996-03-05 2004-05-12 Acusphere, Inc. Gaz fluores micro-encapsules utilises en qualite d'agents d'imagerie
DE69736981D1 (de) 1996-05-01 2007-01-04 Imarx Pharmaceutical Corp In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
DE19626530A1 (de) * 1996-07-02 1998-01-15 Byk Gulden Lomberg Chem Fab MR-Kontrastmittelzubereitungen
EP0918546B1 (fr) * 1996-08-02 2008-10-15 GE Healthcare AS Perfectionnements relatifs aux milieux de contraste
US6017310A (en) * 1996-09-07 2000-01-25 Andaris Limited Use of hollow microcapsules
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles
GB9701237D0 (en) * 1997-01-22 1997-03-12 Nycomed Imaging As Improvements in or relating to contrast agents
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19805012A1 (de) * 1998-02-07 1999-08-12 Thomas Gieselmann Kontrastmittel zur Verwendung als Diagnostikum bei bildgebenden Verfahren sowie seine Herstellung
GB9912356D0 (en) 1999-05-26 1999-07-28 Btg Int Ltd Generation of microfoam
US8512680B2 (en) 2001-08-08 2013-08-20 Btg International Ltd. Injectables in foam, new pharmaceutical applications
US7731986B2 (en) 2003-11-17 2010-06-08 Btg International Ltd. Therapeutic foam
US8048439B2 (en) 2003-11-17 2011-11-01 Btg International Ltd. Therapeutic foam
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
GB0509824D0 (en) 2005-05-13 2005-06-22 Btg Int Ltd Therapeutic foam
WO2007070827A2 (fr) * 2005-12-15 2007-06-21 Bristol-Myers Squibb Pharma Company Agents de contraste pour imagerie de perfusion myocardique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3141641A1 (de) * 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Ultraschall-kontrastmittel und dessen herstellung
US4900540A (en) * 1983-06-20 1990-02-13 Trustees Of The University Of Massachusetts Lipisomes containing gas for ultrasound detection
ZA888577B (en) * 1987-11-27 1989-08-30 Akzo Nv Stabilization of antibodies
IN172208B (fr) * 1990-04-02 1993-05-01 Sint Sa

Also Published As

Publication number Publication date
AU652803B2 (en) 1994-09-08
DE4290068D2 (de) 1993-10-07
HU9301703D0 (en) 1993-09-28
EP0566601B2 (fr) 2007-02-21
FI933137L (fi) 1993-07-08
AU1154792A (en) 1992-08-17
PL167253B1 (pl) 1995-08-31
WO1992011873A1 (fr) 1992-07-23
IL100607A0 (en) 1992-09-06
DK0566601T4 (da) 2007-05-29
HU220763B1 (hu) 2002-05-28
KR100203221B1 (ko) 1999-06-15
SK72993A3 (en) 1994-04-06
IE920038A1 (en) 1992-07-15
RU2091079C1 (ru) 1997-09-27
ES2079176T5 (es) 2007-10-16
SK278776B6 (sk) 1998-02-04
CZ280939B6 (cs) 1996-05-15
CA2098915A1 (fr) 1992-07-10
CZ178093A3 (en) 1994-04-13
NZ241246A (en) 1994-01-26
HK1006147A1 (en) 1999-02-12
US5599523A (en) 1997-02-04
EP0494615A1 (fr) 1992-07-15
HUT64239A (en) 1993-12-28
BG61667B2 (bg) 1998-02-27
CA2098915C (fr) 2005-05-17
ATE126708T1 (de) 1995-09-15
KR930703023A (ko) 1993-11-29
ES2079176T3 (es) 1996-01-01
IE70131B1 (en) 1996-10-30
IL100607A (en) 1996-07-23
DK0566601T3 (da) 1995-12-18
EP0566601A1 (fr) 1993-10-27
DE59203392D1 (de) 1995-09-28
DE4100470A1 (de) 1992-07-16
EP0566601B1 (fr) 1995-08-23
JP2000509363A (ja) 2000-07-25
JP3290655B2 (ja) 2002-06-10
UA27121C2 (uk) 2000-02-28
FI933137A0 (fi) 1993-07-08
ZA92118B (en) 1992-08-26
GR3017925T3 (en) 1996-01-31

Similar Documents

Publication Publication Date Title
FI119913B (fi) Kaikukontrastiaine
FI81008B (fi) Flytande blandning foer mottagning och stabilisering av gasbubblor foer anvaendning som kontrastmedel vid ultraljuddiagnostik.
HK1006147B (en) Echo contrast means
AU681812B2 (en) Method of making suspensions of air or gas filled microbubbles
CN1182373B (zh) 用于超声对比增强的含磷脂的稳定气乳剂
NO314019B1 (no) Ultralydkontrastmedium, kontrastmidler inneholdende mediet og fremgangsmåtederav
JP2019503403A (ja) 脂質組成のマイクロバブル及びその製造方法
JPH0235727B2 (fr)
JP2000504317A (ja) 気泡懸濁物と超音波造影剤への応用
JPH08310971A (ja) 超音波診断用造影剤
US20030206862A1 (en) Contrast medium based on polyoxyethylene-660-12-hydroxystearate and anionic phospholipids
NO309459B1 (no) Ekkokontrastmiddel, samt fremgangsmåte ved fremstilling derav
HK1003293B (en) Improvements in or relating to contrast agents
HK1005795A (en) Improvements in or relating to contrast agents
HK1003293A1 (en) Improvements in or relating to contrast agents
MXPA97006402A (es) Emulsión de gas estabilizada, que contiene fosfolipidos para aumentar el contraste del ultrasonido

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119913

Country of ref document: FI